| Preliminary efficacy and safety results of savolitinib treating patients with pulmonary sarcomatoid carcinoma (PSC) and other types of non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations | |
| Lu, Shun; Fang, Jian; Cao, Lejie; Li, Xingya; Guo, Qisen; Zhou, Jianying; Cheng, Ying; Jiang, Liyan; Chen, Yuan; Zhang, Helong | |
| 2019 | |
| 会议名称 | Annual Meeting of the American-Association-for-Cancer-Research (AACR) |
| 会议日期 | MAR 29-APR 03, 2019 |
| 卷号 | 79 |
| 期号 | 13 |
| DOI | 10.1158/1538-7445.AM2019-CT031 |
| 收录类别 | CPCI-S ; SCIE |
| 会议录 | CANCER RESEARCH
 |
| URL标识 | 查看原文 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6024445 |
| 专题 | 山东大学 |
| 作者单位 | 1.Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China. 2.Peking Univ, Beijing Canc Hosp, Beij |
| 推荐引用方式 GB/T 7714 | Lu, Shun,Fang, Jian,Cao, Lejie,et al. Preliminary efficacy and safety results of savolitinib treating patients with pulmonary sarcomatoid carcinoma (PSC) and other types of non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations[C]. 见:Annual Meeting of the American-Association-for-Cancer-Research (AACR). MAR 29-APR 03, 2019. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论